PharmaCyte Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.About PMCB
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
CEOJoshua Nathaniel Silverman
CEOJoshua Nathaniel Silverman
Employees2
Employees2
HeadquartersLas Vegas, Nevada
HeadquartersLas Vegas, Nevada
Founded1996
Founded1996
Employees2
Employees2
PMCB Key Statistics
Market cap6.12M
Market cap6.12M
Price-Earnings ratio0.28
Price-Earnings ratio0.28
Dividend yield—
Dividend yield—
Average volume51.05K
Average volume51.05K
High today$0.8999
High today$0.8999
Low today$0.85
Low today$0.85
Open price$0.851
Open price$0.851
Volume14.03K
Volume14.03K
52 Week high$2.42
52 Week high$2.42
52 Week low$0.80
52 Week low$0.80
People also own
Based on the portfolios of people who own PMCB. This list is generated using Robinhood data, and it’s not a recommendation.